Rovertis Pharmaceuticals Private Limited
About Rovertis Pharmaceuticals Private Limited
Data last updated:
Rovertis Pharmaceuticals Private Limited is a private limited company based in Telangana, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 04 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044325. Its GSTIN is 36AACCR9866N1ZH (Telangana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹9.56 Lakh. It is led by directors including Krishnam Raju Vegesna and Swarupa Rani Chintala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061.
As per the financials filed for FY 2023, the company reported a revenue of ₹63.34 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Lakh (net margin 2.1%) and EBITDA of ₹1.79 Lakh (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Rovertis Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2004PTC044325. The current CIN is U24239TG2004PTC044325, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044325 | Current |
| U24239AP2004PTC044325 | Previous |
Contact details
Rovertis Pharmaceuticals Private Limited's registered office is in Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Rovertis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rovertis Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Rovertis Pharmaceuticals Private Limited, buy the company report.
Financials of Rovertis Pharmaceuticals Private Limited
FY 2025 filings availableRovertis Pharmaceuticals Private Limited reported revenue of ₹63.34 Lakh (down 10% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 10% fall in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rovertis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rovertis Pharmaceuticals Private Limited
Rovertis Pharmaceuticals has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishnam Raju Vegesna | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Swarupa Rani Chintala Also directs: Swaroop Cosmetics Private Limited | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Padma Rajaboina | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Rajitha Rajaboina | Director | 20 Dec 2010 | 15 Years 10 Months | Current |
| Swarna Latha Pagadala | Director | 04 Oct 2004 | 22 Years 0 Months | Current |
| Sreenivasa Rao Devarakonda | Director | 20 Dec 2010 | 15 Years 10 Months | Current |
Auditor
Rovertis Pharmaceuticals Private Limited is audited by G.SAILEKH RAJ & ASSOCIATES for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.SAILEKH RAJ & ASSOCIATES | FY 2016 | 003518S |
Shareholding
The shareholding of Rovertis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rovertis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rovertis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rovertis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rovertis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCR9866N1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rovertis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rovertis Pharmaceuticals Private Limited has 8 board changes on record since 2004: 6 appointments and 2 cessations. The latest: Rajitha Rajaboina was appointed as Director on 20 Dec 2010.
Frequently asked questions
Rovertis Pharmaceuticals is an active private limited company based in Telangana, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 04 October 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044325.
Rovertis Pharmaceuticals has 6 current directors:
- Krishnam Raju Vegesna - Director
- Swarupa Rani Chintala - Director
- Padma Rajaboina - Director
- Rajitha Rajaboina - Director
- Swarna Latha Pagadala - Director
- Sreenivasa Rao Devarakonda - Director
The latest financial statements of Rovertis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Rovertis Pharmaceuticals is 36AACCR9866N1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Rovertis Pharmaceuticals is U24239TG2004PTC044325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rovertis Pharmaceuticals was incorporated on 04 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rajitha Rajaboina was appointed as Director on 20 Dec 2010. Sreenivasa Rao Devarakonda was appointed as Director on 20 Dec 2010. Srinivas Rajaboina ceased to be Director on 20 Dec 2010. Rovertis Pharmaceuticals has 8 board changes on record in total.
The registered office of Rovertis Pharmaceuticals is at 12 – 11 – 1427 Main Roadbowdhanagar Hyderabad, Telangana, India – 500061.
Rovertis Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Rovertis Pharmaceuticals is active non-compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.